Fludara and Hyperplasia - a phase IV clinical study of FDA data

Summary:

Hyperplasia is reported as a side effect among people who take Fludara (fludarabine phosphate), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Busulfan, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Hyperplasia when taking Fludara. It is created by eHealthMe based on reports of 46,669 people who have side effects when taking Fludara from the FDA, and is updated regularly.

What is Fludara?

Fludara has active ingredients of fludarabine phosphate. eHealthMe is studying from 46,686 Fludara users. Check the latest studies of Fludara.

What is Hyperplasia?

Hyperplasia (enlargement of an organ or tissue) is found to be associated with 313 drugs and 427 conditions by eHealthMe. Check the latest studies of Hyperplasia.

On Jul, 19, 2026

46,669 people reported to have side effects when taking Fludara.
Among them, 12 people (0.03%) have Hyperplasia.

Among these 12 people:

How long have people been on Fludara when they have Hyperplasia? *

What is the gender of people who have Hyperplasia when taking Fludara? *

female: 40 %
male: 60 %

What is the age of people who have Hyperplasia when taking Fludara? *

What are other drugs people take besides Fludara? *

What are other side effects people have besides Hyperplasia? *

Fever: 6 people, 50.00%
Thrombocytopenia (decrease of platelets in blood): 5 people, 41.67%
Herpes Zoster: 4 people, 33.33%
Hypotension (abnormally low blood pressure): 4 people, 33.33%
Jejunal Ulcer (ulcer of the jejunum): 4 people, 33.33%
Enterocolitis Viral: 4 people, 33.33%
Melaena (the passage of black, tarry stools): 4 people, 33.33%
Mucocutaneous Ulceration (breaks in mucous membranes that are often accompanied by loss of tissue on the surface of mouth): 4 people, 33.33%
Mucosal Erosion (peeling off of mucous membrane): 4 people, 33.33%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 4 people, 33.33%

What are the existing conditions these people have? *

Bone Marrow Conditioning Regimen: 7 people, 58.33%
Venoocclusive Liver Disease (small veins in the liver are obstructed): 4 people, 33.33%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 4 people, 33.33%
Aplastic Anemia: 4 people, 33.33%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 8.33%
B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Fludara and have Hyperplasia?

- Check whether Hyperplasia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fludara:

Fludara (46,686 reports)

Hyperplasia treatments and more:

Hyperplasia (1,530 reports)

Browse all side effects of Fludara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperplasia:

Hyperplasia (313 drugs)

Browse all the conditions that are associated with Hyperplasia:

Hyperplasia (427 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fludarabine phosphate (the active ingredients of Fludara) and Fludara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.